<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Bouquet, J.</title>
    <link>http://repub.eur.nl/res/aut/1171/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Growth monitoring to detect children with cystic fibrosis (Article)</title>
      <link>http://repub.eur.nl/res/pub/17807/</link>
      <pubDate>2009-10-13T00:00:00Z</pubDate>
      <description>Background/Aims: Cystic fibrosis (CF) in infancy and childhood is often associated with failure to thrive (FTT). This would suggest that in countries without a newborn screening program for CF, FTT could be used as a clinical screening tool. The aim of this study is to assess the diagnostic performance of FTT for identifying children with CF. Methods: Longitudinal length and weight measurements up to 2.5 years of age were used from CF patients (n = 123) and a reference group (n = 2,151) in The Netherlands. Growth measurements after diagnosis were excluded. We developed five potential screening rules based upon length, weight and body mass index (BMI) standardized by age and gender (SDS). Outcome measures were sensitivity, specificity and positive predictive value (PPV). Results: BMI SDS had the highest sensitivity at low false-positive rates. An efficient scenario is a BMI SDS below -2.5 SD in combination with a decrease in BMI SDS of at least 0.5 SD. This scenario had a sensitivity of 32%, a specificity of 98.3% and a PPV of 0.75%. Conclusion: In the absence of a newborn screening program, young children with FTT for BMI are candidates to consider testing for CF.</description>
    </item> <item>
      <title>A population-based nested case control study on recurrent pneumonias in children with severe generalized cerebral palsy: ethical considerations of the design and representativeness of the study sample. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13869/</link>
      <pubDate>2005-07-19T00:00:00Z</pubDate>
      <description>BACKGROUND: In children with severe generalized cerebral palsy, pneumonias are a major health issue. Malnutrition, dysphagia, gastro-oesophageal reflux, impaired respiratory function and constipation are hypothesized risk factors. Still, no data are available on the relative contribution of these possible risk factors in the described population. This paper describes the initiation of a study in 194 children with severe generalized cerebral palsy, on the prevalence and on the impact of these hypothesized risk factors of recurrent pneumonias. METHODS/DESIGN: A nested case-control design with 18 months follow-up was chosen. Dysphagia, respiratory function and constipation will be assessed at baseline, malnutrition and gastro-oesophageal reflux at the end of the follow-up. The study population consists of a representative population sample of children with severe generalized cerebral palsy. Inclusion was done through care-centres in a predefined geographical area and not through hospitals. All measurements will be done on-site which sets high demands on all measurements. If these demands were not met in "gold standard" methods, other methods were chosen. Although the inclusion period was prolonged, the desired sample size of 300 children was not met. With a consent rate of 33%, nearly 10% of all eligible children in The Netherlands are included (n = 194). The study population is subtly different from the non-participants with regard to severity of dysphagia and prevalence rates of pneumonias and gastro-oesophageal reflux. DISCUSSION: Ethical issues complicated the study design. Assessment of malnutrition and gastro-oesophageal reflux at baseline was considered unethical, since these conditions can be easily treated. Therefore, we postponed these diagnostics until the end of the follow-up. In order to include a representative sample, all eligible children in a predefined geographical area had to be contacted. To increase the consent rate, on-site measurements are of first choice, but timely inclusion is jeopardized. The initiation of this first study among children with severe neurological impairment led to specific, unexpected problems. Despite small differences between participants and non-participating children, our sample is as representative as can be expected from any population-based study and will provide important, new information to bring us further towards effective interventions to prevent pneumonias in this population.</description>
    </item> <item>
      <title>Bone mineral density and nutritional status in children with chronic inflammatory bowel disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/8803/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Osteoporosis has been reported in adult patients with
          inflammatory bowel disease. AIMS: To evaluate bone mineral density (BMD),
          nutritional status, and determinants of BMD in children with inflammatory
          bowel disease. PATIENTS: Fifty five patients (34 boys and 21 girls, age
          range 4-18) were studied; 22 had Crohn's disease and 33 ulcerative
          colitis. METHODS: Lumbar spine and total body BMD, and body composition
          were assessed by dual energy x ray absorptiometry (DXA). Results were
          expressed as standard deviation scores (SDS). Lean body mass was also
          assessed by bioelectrical impedance analysis (BIA). Yearly measurements
          during two years were performed in 21 patients. RESULTS: The mean SDS of
          lumbar spine BMD and total body BMD were significantly lower than normal
          (-0.75 and -0.95, both p &lt; 0.001). Height SDS and body mass index SDS were
          also decreased. The decrease in BMD SDS could not be explained by delay in
          bone maturation. The cumulative dose of prednisolone correlated negatively
          with lumbar spine BMD SDS (r = -0.32, p &lt; 0.02). Body mass index SDS
          correlated positively with total body BMD SDS (r = 0.36, p &lt; 0.02).
          Patients with Crohn's disease had significantly lower lumbar spine and
          total body BMD SDS than patients with ulcerative colitis, even after
          adjustment for cumulative dose of prednisolone. In the longitudinal data
          cumulative dose of prednisolone between the measurements correlated
          negatively with the change in lumbar spine and total body BMD SDS. Lean
          tissue mass measured by DXA had a strong correlation with lean body mass
          measured by BIA (r = 0.98). CONCLUSIONS: Children with inflammatory bowel
          disease have a decreased BMD. Children with Crohn's disease have a higher
          risk of developing osteopaenia than children with ulcerative colitis.
          Corticosteroid therapy and nutritional status are important determinants
          of BMD in these patients.</description>
    </item>
  </channel>
</rss>